MET Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

31.44B

+59.3%

2.362

+13.02%

19.03B

+1.07%

2.235

+14.04%

19.68B

+9.81%

2.522

+24.83%

Estimates Revision

The market is revising Upward the revenue expectations for MetLife, Inc. (MET) for FY2025, with the revenue forecasts being adjusted by 13.95% over the past three months. During the same period, the stock price has changed by -2.68%.

Revenue Estimates for FY2025

Revise Upward

+13.95%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.14%

In Past 3 Month

Stock Price

Go Down

-2.68%

In Past 3 Month

12 Analyst Rating

Wall Street analysts forecast MET stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MET is 92.42 USD with a low forecast of 84.00 USD and a high forecast of 100.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

10 Buy

2 Hold

0 Sell

Strong Buy

Current: 0.000

Low

84.00

Averages

92.42

High

100.00

Current: 0.000

Low

84.00

Averages

92.42

High

100.00

Evercore ISI

Outperform -> In Line

downgrade

$108 -> $97

2026-01-06

New

Reason

Evercore ISI

Price Target

$108 -> $97

2026-01-06

New

downgrade

Outperform -> In Line

Reason

Evercore ISI downgraded MetLife to In Line from Outperform with a price target of $97, down from $108, and removed MetLife from the Evercore ISI Core List. Despite a solid Q3 earnings print, the downgrade reflects potential downside to forward earnings, relatively high valuation versus mid-cap peers, and pressure from low new-money spreads alongside higher commercial mortgage loan risk, which could hurt both multiples and earnings if credit or commercial real estate conditions worsen, the analyst tells investors in a research note. While additional risk transfer deals could be a catalyst, execution may be delayed as the company appears willing to wait for better pricing, particularly in long-term care where margins and cash flow remain positive.

BofA

Joshua Shanker

Buy

downgrade

$100 -> $98

2026-01-05

New

Reason

BofA

Joshua Shanker

Price Target

$100 -> $98

2026-01-05

New

downgrade

Buy

Reason

BofA analyst Joshua Shanker lowered the firm's price target on MetLife to $98 from $100 and keeps a Buy rating on the shares. As in 2025, the pricing trends for most P&C insurance products do not appear positive, the analyst tells investors in a research note. While pricing for liability lines remains positive, it seems that loss costs are rising more steeply than prices, the analyst says, adding that personal auto rates are flattish, while some investors are expecting decline in response to high profitability. The firm added, however, that underwriter valuations hardly look expensive, even as fundamentals have tipped in the "wrong direction."

Morgan Stanley

Overweight

maintain

$97 -> $101

2025-12-15

Reason

Morgan Stanley

Price Target

$97 -> $101

2025-12-15

maintain

Overweight

Reason

Morgan Stanley raised the firm's price target on MetLife to $101 from $97 and keeps an Overweight rating on the shares. Lower interest rates and a steady or better equity market should serve as the broader macro backdrops and 2026 should see "similar fundamental trends as 2025," the analyst tells investors in a life insurance group outlook note.

Mizuho

Outperform

initiated

$101

2025-12-15

Reason

Mizuho

Price Target

$101

2025-12-15

initiated

Outperform

Reason

Mizuho initiated coverage of MetLife with an Outperform rating and $101 price target. The firm rolled out coverage of 23 companies, including six life insurers, 11 property and casualty insurers and six insurance brokers. It prefers life insurance, saying the group is undervalued despite credit concerns. Mizuho is less constructive on the property and casualty insurers and brokers citing market softening, plateauing investment yields and reserve concerns. The analyst expects insurance broker organic growth to moderate and is concerned that this may drive more aggressive acquisitions.

Argus

Buy

maintain

$90

2025-12-09

Reason

Argus

Price Target

$90

2025-12-09

maintain

Buy

Reason

Argus keeps a Buy rating and $90 price target on MetLife, noting that the firm has a positive view of the company's business diversification, expansion through both M&A and organic growth, and its commitment to shareholder returns. The stock trades at 1.4-times book value, in line with the peer median, but as an industry leader, it merits a higher multiple, the analyst tells investors in a research note.

Morgan Stanley

Michael Harleaux

Equal Weight

maintain

2025-12-05

Reason

Morgan Stanley

Michael Harleaux

Price Target

2025-12-05

maintain

Equal Weight

Reason

Morgan Stanley analyst Michael Harleaux raised the firm's price target on Metso to EUR 13.20 from EUR 10.80 and keeps an Equal Weight rating on the shares.

Valuation Metrics

The current forward P/E ratio for MetLife Inc (MET.N) is 8.29, compared to its 5-year average forward P/E of 8.46. For a more detailed relative valuation and DCF analysis to assess MetLife Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

8.46

Current PE

8.29

Overvalued PE

9.45

Undervalued PE

7.46

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

3.80

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

9.73

Undervalued EV/EBITDA

-2.13

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.72

Current PS

0.59

Overvalued PS

0.80

Undervalued PS

0.65

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 119940.49% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

MET News & Events

Events Timeline

No data

News

8.0

01-07NASDAQ.COM

Duke Energy Declares $1.065 Quarterly Cash Dividend Per Share

8.0

01-06Newsfilter

MetLife Declares $0.5675 Dividend per Share for Q1 2026

8.0

01-02NASDAQ.COM

Adobe (ADBE) and MetLife (MET) Options Show Significant Volume Surge

People Also Watch

Frequently Asked Questions

What is MetLife Inc (MET) stock price today?

The current price of MET is 79.78 USD — it has increased 1.93 % in the last trading day.

What is MetLife Inc (MET)'s business?

MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.

What is the price predicton of MET Stock?

What is MetLife Inc (MET)'s revenue for the last quarter?

MetLife Inc revenue for the last quarter amounts to 17.38B USD, decreased -6.08 % YoY.

What is MetLife Inc (MET)'s earnings per share (EPS) for the last quarter?

MetLife Inc. EPS for the last quarter amounts to 1.22 USD, decreased -32.60 % YoY.

What changes have occurred in the market's expectations for MetLife Inc (MET)'s fundamentals?

How many employees does MetLife Inc (MET). have?

MetLife Inc (MET) has 45000 emplpoyees as of January 09 2026.

What is MetLife Inc (MET) market cap?

Today MET has the market capitalization of 52.57B USD.